Comparative Analysis of Immune Profile Following Neoadjuvant Chemotherapy in Colorectal Liver Metastases (CRLM): A Prospective Pilot Clinical Trial
Phase of Trial: Phase II
Latest Information Update: 29 May 2019
Price : $35 *
At a glance
- Drugs Atezolizumab (Primary) ; Bevacizumab (Primary) ; Fluorouracil (Primary) ; Folinic acid (Primary) ; Oxaliplatin (Primary)
- Indications Adenocarcinoma; Colorectal cancer; Liver metastases
- Focus Pharmacodynamics
- Acronyms CLIMB
- 15 May 2019 Status changed from not yet recruiting to recruiting.
- 30 Dec 2018 Planned initiation date changed from 1 Dec 2018 to 1 Feb 2019.
- 16 Oct 2018 New trial record